Compared to CD115+ M-MDSCs, CD115− M-MDSCs had more frequent PMN-MDSC (CD11b+Ly6G+Ly6Clo) differentiation in BM, blood, and liver, but not in the tumor mass (Fig. 4b). This evidence concerns the gene ITGAM and neoplasm.